ATE512985T1 - Diagnostische und therapeutische anwendungen von löslichem lhcgr-protein - Google Patents

Diagnostische und therapeutische anwendungen von löslichem lhcgr-protein

Info

Publication number
ATE512985T1
ATE512985T1 AT05734038T AT05734038T ATE512985T1 AT E512985 T1 ATE512985 T1 AT E512985T1 AT 05734038 T AT05734038 T AT 05734038T AT 05734038 T AT05734038 T AT 05734038T AT E512985 T1 ATE512985 T1 AT E512985T1
Authority
AT
Austria
Prior art keywords
lhcgr
protein
soluble
diagnostic
therapeutic uses
Prior art date
Application number
AT05734038T
Other languages
English (en)
Inventor
Subhasis Banerjee
Original Assignee
Subhasis Banerjee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Subhasis Banerjee filed Critical Subhasis Banerjee
Application granted granted Critical
Publication of ATE512985T1 publication Critical patent/ATE512985T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT05734038T 2004-04-15 2005-04-15 Diagnostische und therapeutische anwendungen von löslichem lhcgr-protein ATE512985T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0408449.7A GB0408449D0 (en) 2004-04-15 2004-04-15 Diagnostic and therapeutic applications of soluble lhcge protein
PCT/GB2005/001473 WO2005100397A1 (en) 2004-04-15 2005-04-15 Diagnostic and therapeutic applications of soluble lhcgr protein

Publications (1)

Publication Number Publication Date
ATE512985T1 true ATE512985T1 (de) 2011-07-15

Family

ID=32320901

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05734038T ATE512985T1 (de) 2004-04-15 2005-04-15 Diagnostische und therapeutische anwendungen von löslichem lhcgr-protein

Country Status (7)

Country Link
US (1) US7892753B1 (de)
EP (1) EP1751189B1 (de)
AT (1) ATE512985T1 (de)
AU (1) AU2005233362A1 (de)
CA (1) CA2563578A1 (de)
GB (1) GB0408449D0 (de)
WO (1) WO2005100397A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006331093B2 (en) * 2005-12-29 2011-11-24 Humanitas Mirasole S.P.A. Diagnostic test for inflammatory endothelial dysfunctions in pregnancies
JP2010503840A (ja) * 2006-09-14 2010-02-04 ゾラ バイオサイエンシズ オイ 自己免疫および１型糖尿病のリスクの早期予測ツールとしての生体流動の代謝体プロファイリング
JP2017521452A (ja) * 2014-07-15 2017-08-03 ズィートチック・リサーチ・インスティチュート・エルエルシーＺｉｅｔｃｈｉｃｋ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ， Ｌｌｃ 眼障害の予防又は治療の方法
CN107530427A (zh) 2015-03-27 2018-01-02 南加利福尼亚大学 针对用于实体肿瘤的治疗的lhr的car t细胞疗法
WO2016162037A1 (en) * 2015-04-08 2016-10-13 Rigshospitalet Copenhagen Universtiy Hospital Lhcgr for use in diagnosing and monitoring of andrological diseases
EP3302559B1 (de) 2015-06-04 2022-01-12 University of Southern California Auf lym-1 und lym-2 abgerichtete car-zellen-immuntherapie
EP3515493A4 (de) * 2016-09-23 2020-08-19 University of Southern California Chimäre antigenrezeptoren sowie zusammensetzungen und verfahren zur verwendung davon

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
ATE181746T1 (de) 1990-09-10 1999-07-15 Takeda Chemical Industries Ltd Menschlicher rezeptor für luteinisierendes hormon und choriongonadotropin
AU2728297A (en) 1996-04-15 1997-11-07 Board Of Trustees Of The Leland Stanford Junior University Soluble 7-transmembrane domain G-protein-coupled receptor compositions and me thods
EP1022027A1 (de) 1999-01-22 2000-07-26 Applied Research Systems ARS Holding N.V. Antagonisten von Tumornecrosefaktor und ihre Verwendungen gegen Endometriose
WO2002061087A2 (en) * 2000-12-19 2002-08-08 Lifespan Biosciences, Inc. Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides

Also Published As

Publication number Publication date
EP1751189A1 (de) 2007-02-14
WO2005100397A1 (en) 2005-10-27
US7892753B1 (en) 2011-02-22
CA2563578A1 (en) 2005-10-27
GB0408449D0 (en) 2004-05-19
EP1751189B1 (de) 2011-06-15
AU2005233362A1 (en) 2005-10-27

Similar Documents

Publication Publication Date Title
DE60220719D1 (de) Antikörper gegen das muc18-antigen
DE60225673D1 (de) Kappa-opioid-rezeptor-liganden
CY1110721T1 (el) Χρηση glp-2 σε συνδυασμο με αλλο θεραπευτικο παραγοντα σε οστικες παθησεις
ATE502052T1 (de) Monoklonale antikörper gegen den humanen anti- müllerian-hormonrezeptor vom typ ii (amhr-ii)
CY1118660T1 (el) Συνθεσεις και μεθοδοι για την θεραπεια διαταραχων ματιων
EA200600055A1 (ru) Агонисты рецептора меланокортина 4 (мк4 ) и их применение
FR13C0068I2 (fr) Conjugues du maytansinoide dm1 avec l'anticorps trastuzumab, attache par une liaison non-clivable, et son utilisation dans le traitement des tumeurs.
TR200102021T2 (tr) TWEAK ve TWEAK reseptörü antagonistleri ve bunların imünolojik bozuklukların iyileştirilmesi için kullanımları
NO20070294L (no) Gonadotropinfrigjorende hormon reseptor antagonister
WO2008070137A3 (en) Interferon alpha-induced pharmacodynamic markers
HUP0301877A2 (hu) Aromatáz inhibitorok és monoklonális anti-HER2 ellenanyagok mint tumorellenes szerek
JP2005537234A5 (de)
UY27392A1 (es) Derivados del ácido indan acetico y su uso como agentes farmacéuticos, intermediarios, y método de preparación
DK1450811T3 (da) Forbindelser specifikke af adenosin A1- og A3-receptorer og anvendelser heraf
EA200401341A1 (ru) Применение остеопротегерина для лечения и/или профилактики фиброзного заболевания
DE60324431D1 (de) Derivate des 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazols als antagonisten des gonadotropin freisetzenden hormons (gnrh) zur anwendung in de behandlung von geschlechtshormonellen erkrankungen, wie prostata- oder gebahrmutterkrebs
GB0408449D0 (en) Diagnostic and therapeutic applications of soluble lhcge protein
ATE486890T1 (de) Ephb-rezeptorbindende peptide
BRPI0518296A2 (pt) antagonistas do receptor do hormânio liberador de gonadotropina
BR0010709A (pt) Gonadotrofinas
MXPA04001113A (es) Formacion de imagenes simultaneas de perfusion cardiaca y agente formador de imagenes dirigido al receptor de vitronectina.
EP1488807A4 (de) Mittel zur behandlung von sexualhormonabhängigen erkrankungen
DE60141297D1 (de) Gegen das menschliche bst2 antigen gerichteter monoklonaler antikörper
BRPI0407031A (pt) Composições e métodos para tratamento de câncer empregando igsf9 e liv-1
MA33579B1 (fr) Thérapie anti-angiogenèse pour le traitement d'un cancer du sein précédemment traité

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties